原著論文1
S. Matsuoka-Aizawa, H. Sato, A. Hachiya, et al.
Isolation and molecular characterization of a nelfinavir (NFV)-resistant human immunodeficiency virus type 1 that exhibits NFV-dependent enhancement of replication.
J. Virology
, 77
(1)
, 318-327
(2003)
原著論文2
K. Tsuchiya, S. Matsuoka-Aizawa, A. Yasuoka, et al.
Primary nelfinavir (NFV)-associated resistance mutations during a follow-up period of 108 weeks in protease inhibitor naïve patients treated with NFV-containing regimens in an HIV clinic cohort.
J. Clinical Virology
, 27
, 252-262
(2003)
原著論文3
A. Hachiya, S. Matsuoka-Aizawa, K. Tsuchiya, et al.
“All-in-One”, a direct phenotypic anti-human immunodeficiency virus type 1 drug resistance assay for three-drug combination therapies that takes into consideration in vivo drug aoncentrations.
J. Virological Methods
, 111
, 43-53
(2003)
原著論文4
X. Bi, H. Gatanaga, S. Ida, et al.
Emergence of protease inhibitor resistance-associated mutations in plasma HIV-1 precedes that in proviruses of peripheral blood mononuclear cells by more than a year.
J. Acquir. Immune. Defic. Syndr.
, 34
, 1-6
(2003)
原著論文5
J. Tanuma, A. Ishizaki, H. Gatanaga, et al.
Dilated cardiomyopathy in an adult human immunodeficiency virus type 1-positive patient treated with a zidovudine-containing antiretroviral regimen.
Clinical Infectious Diseases
, 37
, 109-111
(2003)
原著論文6
H. Ueda, H. Gatanaga, Y. Kikuchi, et al.
Bilateral lesions in the basal ganglia of a patient with acquired immunodeficiency syndrome.
Clinical Infectious Diseases
, 37
, 978-979
(2003)
原著論文7
Y. Yamamoto, K. Teruya, H. Katano, et al.
Rapidly progressive human herpesvirus 8-associated solid anaplastic lymphoma in a patient with AIDS – associated Kaposi sarcoma.
Leukemia & Lymphoma
, 44
(9)
, 1631-1633
(2003)
原著論文8
J. Song, A. Yoshida, Y. Yamamoto, et al.
Viral load of human herpesvirus 8 (HHV-8) in the circulatory blood cells correlates with clinical progression in a pacient with HHV-8-associated solid lymphoma with AIDS-associated Kaposi’s sarcoma.
Leukemia & Lymphoma
, 45
(11)
, 2343-2347
(2004)
原著論文9
M. Watanabe, K. Nishimura, T. Inoue, et al.
A discriminative study of health-related quality of life assessment in HIV-1-infected persons living in Japan using the Multidimensional Quality of Life Questionnaire for persons with HIV/AIDS.
International J. STD & AIDS
, 15
, 107-115
(2004)
原著論文10
K. Tsuchiya, H. Gatanaga, N. Tachikawa, et al.
Homozygous CYP2B6*6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.
Biochem. Biophy. Res. Commun.
, 319
, 1322-1326
(2004)
原著論文11
K. Wada, H. Nagai, T. Hagiwara, et al.
Delayed HIV-1 Infection of T Lymphocytes from Therapy-Naïve Patients Demonstrated by Quantification of HIV-1 DNA Copy Numbers.
Microbiol. Immunol.
, 48
, 767-772
(2004)
原著論文12
T. Oki, Y. Usami, M. Nakai, et al.
Pharmacokinetics of Lopinavir after Administration of Karetra in Healthy Japanese Volunteers.
Biol. Phar. Bull.
, 27
, 261-265
(2004)
原著論文13
X. Bi, H. Gatanaga, M. Tanaka, et al.
Modified dynabeads method for enumerating CD4+ T-lymphocyte count for widespread use in resource-limited situations.
J. Acquir. Immune. Defic. Syndr.
, 38
(1)
, 1-4
(2005)
原著論文14
H. Yamanaka, K. Teruya, M. Tanaka, et al.
Efficacy and immunologic responses to influenza vaccine in HIV-1-infected patients.
J. Acquir. Immune. Defic Syndr.
, 39
(2)
, 167-173
(2005)
原著論文15
Y. Otsuka, T. Fujino, N. Mori, et al.
Survey of human immunodeficiency virus (HIV)-seropositive patients with mycobacterial infection in Japan.
J. Infect.
, 51
, 364-374
(2005)
原著論文16
Y. Hirabayashi, K. Tsuchiya, S. Kimura, et al.
Simultaneous determination of six HIV protease inhibitors, the active metabolite of nelfinavir (M8) and non-nucleoside reverse transcriptase inhibitor (efavirenz) in human plasma by high-performance liquid chromatography.
Biomed. Chromatogr.
, 20
, 28-36
(2006)
原著論文17
H. Yan, T. Chiba, N. Nomura, et al.
A novel small molecular weight compound with a carbazole structure that demonstrates potent human immunodeficiency virus type-1 integrase inhibitory activity.
Antiviral Chemistry & Chemotherapy
, 16
, 363-373
(2005)
原著論文18
K. Miyauchi, J. Komano, Y. Yokomaku, et al.
Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion.
J. Virology
, 79
(8)
, 4720-4729
(2005)
原著論文19
K. Shiomi, R. Matsui, M. Isozak, et al.
Fungal phenalenones inhibit HIV-1 integrase.
J. Antibiot.
, 58
(1)
, 65-68
(2005)
原著論文20
H. Nagai, K, Wada, T. Morishita, et al.
New estimation method for highly sensitive quantitation of human immunodeficiency virus type 1 DNA and its application.
J. Virological Methods
, 124
, 157-165
(2005)
